The only legitimate access to some compounds comes through clinical trials
SGLT2-i induced natriuresis and glomerular hemodynamics changes resemble, even partially, those observed with sacubitril/valsartan, a first in-class angiotensin receptor neprilysin inhibitor (ARNi)
"Pramlintide in the treatment of diabetes mellitus"
Additionally, it reduces labile iron, as confirmed by calcein fluorescence assays, further supporting its iron-complexing properties (114)
Its ability to remember patient history allows for highly personalized care, making it an excellent tool for those navigating the complexities of combination therapies like cagrlintide and tirzepatide
Example: A comprehensive review published in the Journal of Endocrinological Investigation discusses the physiological effects of GLP-1 receptor agonists on the gallbladder, summarizing current knowledge and identifying areas for future research